Previous Article | Next Article ![]()
Journal of Virology, October 2007, p. 11381-11391, Vol. 81, No. 20
0022-538X/07/$08.00+0 doi:10.1128/JVI.00767-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Ludwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, Box 240, SE-17177 Stockholm, Sweden,1 University of Texas Medical Branch, Department of Pathology, 301 University Boulevard, Galveston, Texas 77555-06092
Received 10 April 2007/ Accepted 24 July 2007
|
|
|---|
|
|
|---|
An infectious VLP system has been developed for UUK virus (30), a member of the Phlebovirus genus, one of five genera in the Bunyaviridae family, and a model virus for this family of viruses (7). These VLPs were shown to be able to package an artificial RNA segment, a minigenome containing a reporter gene flanked by the noncoding regions from one of the three viral segments (8, 30). These VLPs can infect new cells and transfer the minigenome that can be replicated and transcribed in these newly infected cells if the required UUK proteins (the polymerase and nucleoprotein, open reading frames of the L and the S segment, respectively) are coexpressed (30). The VLPs display morphology and cellular tropism identical to those of wild-type (wt) UUK virus (30) and are therefore a useful system for studying packaging and budding mechanisms of this family of viruses. This system has been successfully used to map amino acids in the GN cytoplasmic tail, which is important for the packaging of RNPs into VLPs for UUK virus (29). In addition to the four amino acids located in the end of the GN cytoplasmic tail demonstrated to be important for packaging, two other regions were shown to be important for the generation and release of VLPs. These two regions were shown to span residues 21 to 25 and 46 to 50 in the GN cytoplasmic tail (29). In the present study, we have analyzed and identified specific amino acids within these two regions in the GN cytoplasmic tail that are responsible for the generation and release of VLPs. Moreover, a functional motif within the GC cytoplasmic tail containing a well-conserved lysine residue was shown to be important for proper targeting and retention of both glycoproteins to the Golgi complex and subsequent particle release.
|
|
|---|
Cell culture and transfection. BHK-21 (ATCC) cells were grown in plastic dishes in minimum essential medium with Earle's salt supplemented with 5% fetal calf serum, 5% tryptose phosphate broth, 2 mM L-glutamine, 50 IU penicillin/ml, and 50 µg streptomycin/ml (Invitrogen). For the VLP reporter gene system (30), BHK-21 cells were transfected with pUUK-L, pUUK-N, pUUK-GN/GC, and M-CAT using Lipofectamine 2000 reagent (Invitrogen). Transfections were performed as described previously (29, 30). Cells were analyzed for reporter gene expression 24 h posttransfection, and the corresponding supernatants were used for VLP infection. Twenty-four hours prior to the passage of the supernatant, BHK-21 cells were transfected with L and N expression plasmids in order to support minigenome replication, transcription, and detection. After a 3-h incubation period, fresh medium was added to the VLP-infected cells, and cells were incubated for 24 h before reporter gene analysis.
CAT assays. Cells were resuspended in 50 µl of 0.25 M Tris-HCl (pH 7.4) and were lysed by two freeze-thaw cycles. The cell lysates were centrifuged for 10 min at 9,000 x g, and CAT activity was determined using a commercially available Fast Cat kit (Invitrogen) as described previously (9). The reaction products were visualized by UV illumination and were documented by photography.
Harvesting and purification of UUK VLPs. The harvesting and purification of UUK VLPs were done as previously described (30). Briefly, supernatants from VLP-expressing cells were collected and clarified by centrifugation (4,000 x g for 10 min at 4°C). The particles were concentrated through a 20% (wt/vol) sucrose cushion and dissolved in TN buffer (0.05 M Tris-HCl, pH 7.4, and 0.1 M NaCl) by centrifugation at 100,000 x g for 1 h at 4°C. The pellet was dried for 10 min before resuspension in nonreducing Laemmli/sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer for subsequent analysis.
Western blotting. Precast 10% polyacrylamide gels (Invitrogen) were used according to the manufacturer's recommendations and run under nonreducing conditions. Rabbit polyclonal antibodies recognizing both GN and GC were used to detect GN and GC simultaneously, and polyclonal antibodies recognizing the UUK virus N protein were used to detect the N protein (23).
Immunofluorescence microscopy. BHK-21 cells were grown on coverslips, transfected with mutant or wt glycoprotein, and fixed 24 h posttransfection with 3% paraformaldehyde, and staining was performed as described previously (29). For the cycloheximide treatment, BHK-21 cells were treated 5 h posttransfection with 50 µg/ml cycloheximide for 4 h before fixation with paraformaldehyde. The UUK virus glycoproteins GN/GC and Golgi marker protein GM130 were detected using a mix of polyclonal UUK virus GN/GC antibodies and monoclonal GM130 antibodies (BD Biosciences), followed by Alexa Fluor 488-conjugated goat anti-rabbit immunoglobulin G and Alexa Fluor 594-conjugated goat anti-mouse immunoglobulin G (Molecular Probes). Polyclonal antibodies recognizing the GN cytoplasmic tail (K1228) (42) and monoclonal antibodies recognizing the GN (6G9) or GC (8B11) protein (31) were used to detect each of the glycoproteins separately. Images were collected using a Zeiss microscope equipped with a charge-coupled-device camera.
Glycosidase treatment. BHK-21 cells were transfected with wt GN or with the mutant GN23-24, GN46-47, or GN48-50, and 24 h posttransfection the cells were lysed and 30 µg cell lysate was treated with 12.5 mU endoglycosidase H (Endo H) or 2.5 U N-glycosidase F (PNGase F) (Roche), as described by the manufacturer, or was left untreated.
FACS and transmission electron microscopy (TEM). BHK-21 cells were cotransfected with a green fluorescent protein (GFP) expression plasmid (pHL2823) and the wt GN/GC or the GNL23A/wt GC mutant plasmid at a ratio of 1:2 and trypsinized 24 h posttransfection, and approximately one million GFP-expressing cells were sorted out by fluorescent-activated cell sorting (FACS) analysis. The cells expressing GFP were collected, and an aliquot was plated onto coverslips for immunofluorescence analysis. The remaining cells were fixed and prepared for ultrathin-section electron microscopy, as described previously (30). Cells plated onto coverslips were incubated at 37°C for 16 h and were processed for immunofluorescent staining as described above.
|
|
|---|
![]() View larger version (52K): [in a new window] |
FIG. 1. Transfer of reporter gene activity and protein analysis of VLPs generated by GN glycoprotein mutants. (A) Schematic representation of the glycoprotein precursor open reading frame. The amino acid sequences of GN and GC cytoplasmic tails are shown, and functional motifs that were previously identified are highlighted. Underlined residues are analyzed in the present study using a mutagenesis screen. TM, transmembrane domain; SS, signal sequence. (B and C) Transfer of CAT activity by VLPs generated with mutated and wt glycoproteins. BHK-21 cells were transfected with the minigenome pUUK-N and pUUK-L were left untransfected (lane 1), were transfected with wt GN/GC (lane 2), or were transfected with mutated pUUK-GN/wt GC (lanes 3 to 5). The amino acid residues in the GN tail that were mutated to alanines are indicated by their numbers according to the GN sequence shown in panel A. Cells were harvested and analyzed for CAT activity 24 h posttransfection (upper panel). The corresponding supernatants, containing VLPs, were used to infect new cells pretransfected with pUUK-N and pUUK-L, and reporter activity was determined 24 h after VLP infection (lower panels). (D) Western blot analysis of the VLPs. Transfected cells (upper panels) and the corresponding supernatants containing VLPs, after concentration through a sucrose cushion (lower panels), were analyzed for glycoprotein (GN/GC) and nucleoprotein (N) expression. BHK-21 cells were transfected with M-CAT, pUUK-N, and pUUK-L (lane 1); with M-CAT, pUUK-N, pUUK-L, and wt GN/GC (lane 2); or with mutated pUUK-GN/wt GC (lanes 3 to 5). The two glycoproteins are detected with a polyclonal antibody recognizing both GN and GC, and the nucleoprotein was detected with polyclonal antibody recognizing the N protein. Data represent results from three independent experiments.
|
Intracellular localization of the GN cytoplasmic tail mutants. UUK virus buds into the Golgi complex and is transported in large vesicles to the plasma membrane, where they are released into the media (23). We wondered if the defect in VLP release of these three glycoprotein mutants is caused by mislocalization of the mutant glycoproteins, thereby preventing budding into the Golgi complex. BHK-21 cells transfected with wt GN/GC and the mutants GN23-24, GN46-47, and GN48-50 were fixed 24 h posttransfection and were costained with a polyclonal antibody recognizing both GN and GC glycoproteins and the Golgi marker GM130, a cis-Golgi matrix protein (27) (Fig. 2A). In wt GN/GC-transfected and GN23-24 mutant-transfected cells, the glycoproteins colocalized with the Golgi marker, demonstrating that the lack of reporter gene transfer and release of particles for this mutant was not caused by a defect in intracellular targeting (Fig. 2A). In contrast, the GN46-47 and GN48-50 mutants displayed more reticular staining patterns typically observed for proteins localized to the ER (Fig. 2A, lower panels).
![]() View larger version (19K): [in a new window] |
FIG. 2. Intracellular localization of GN glycoprotein mutants. (A) BHK-21 cells grown on coverslips were transfected with wt or mutant GN glycoprotein as described in the legend to Fig. 1, fixed, permeabilized, and stained 24 h posttransfection for immunofluorescence analysis. Cells were costained with monoclonal antibodies recognizing the Golgi marker GM130 (red) and a polyclonal antibody recognizing both GN and GC glycoproteins (green). Colocalization of the glycoproteins with GM130 is shown in yellow in the right panels. Numbers at the left side indicate the regions in the GN tail that were mutated to alanines. (B) Endo H and PNGase F treatment of wt and mutated glycoproteins. BHK-21 cells were transfected with the wt and mutated glycoproteins as indicated in the figure. The cells were lysed 24 h posttransfection, and the lysates were treated with Endo H (lanes 2, 4, 6, and 8), were left untreated (lanes 1, 3, 5, 7, and 9), or were treated with PNGase F (lane 10). The different forms of the GN protein were detected by Western blotting with an antibody recognizing GN. The fully glycosylated form of GN is indicated by an arrow, and the fully deglycosylated form is indicated by an arrowhead.
|
Identification of residues important for the formation of VLPs. In order to identify which of the two amino acid residues, leucine 23 or leucine 24, is important for the generation and release of VLPs, single-amino-acid mutants GNL23A and GNL24A were generated. Both GNL23A and GNL24A displayed a clear Golgi staining pattern identical to that of wt GN/GC (data not shown), verifying their correct intracellular targeting. The mutants GNL23A and GNL24A were analyzed for their ability to generate and release VLPs and transfer CAT activity to new cells. Supernatants from wt and mutant glycoprotein-transfected cells were collected 24 h posttransfection, an aliquot was used for VLP infection, and the remainder of the supernatant was concentrated and used for Western blot analysis (Fig. 3). The primary transfected cells were harvested, and reporter protein expression was determined using the CAT assay (Fig. 3A, upper panel). All transfected cells showed strong reporter activity, verifying efficient transcription and replication of the UUK virus minigenome. Strong CAT activity also was detected in cells infected with wt VLPs (Fig. 3A, lower panel, lane 1). Transfer of CAT activity was greatly reduced compared to that of the wt for the GNL24A mutant (compare lane 1 with lane 3), while only background levels could be observed with the GNL23A mutant (lane 2). Both glycoproteins and the nucleoprotein were detected in VLPs generated from wt GN/GC-transfected cells. However, no glycoproteins or nucleoproteins were detected in the supernatant obtained from GNL23A- or GNL24A-transfected cells (Fig. 3B). These results show that both residues L23 and L24 are important for the generation and release of VLPs into the medium.
![]() View larger version (23K): [in a new window] |
FIG. 3. GNL23A and GNL24A glycoprotein mutants fail to generate VLPs. (A) CAT analysis of VLPs generated with the single-amino-acid mutants GNL23A and GNL24A. Cell lysates from the transfected cells were analyzed for CAT activity (upper panel), and the corresponding supernatants were harvested, used for VLP infection, and analyzed for CAT expression 48 h postinfection (lower panel). The asterisk indicates the cellular background. (B) Western blot analysis of supernatants containing VLPs used for infection shown in panel A. Both glycoproteins (GN/GC) and the nuclear protein (N) were detected using polyclonal antibodies as described in the legend to Fig. 1. Data are representative results from three independent experiments.
|
![]() View larger version (63K): [in a new window] |
FIG. 4. Morphological analysis of wt and GNL23A glycoprotein-transfected cells. (A) Immunofluorescence analysis of wt and GNL23A glycoprotein-transfected cells after enrichment by FACS. BHK-21 cells were cotransfected with GFP and wt GN/GC or GNL23A mutant glycoprotein in the presence of wt GC. GFP-expressing cells were selected by FACS 24 h posttransfection. An aliquot of the sorted cells was plated on coverslips and stained with a polyclonal antibody recognizing both glycoproteins (red) and 4',6'-diamidino-2-phenylindole (DAPI) (white). Almost all sorted cells express wt GN/GC or the L23A mutant, as shown in the merged images to the right. (B) TEM of FACS-sorted cells expressing the wt or GNL23A mutant. The cells expressing GFP were fixed and processed for ultrathin-section TEM. The Golgi region is indicated by a rectangle in both wt and GNL23A glycoprotein-transfected cells. Only in the wt GN/GC-expressing cells could VLPs be detected, as indicated by the arrows. Bars, 0.5 µm.
|
![]() View larger version (20K): [in a new window] |
FIG. 5. VLP generation is linked to the intracellular localization of the glycoproteins. (A) CAT activity in cells infected with VLPs collected from cells transfected with GN single-amino-acid mutants and wt GC. Point mutations in the region of residues 46 to 50 of the GN cytoplasmic tail were introduced by changing each amino acid to an alanine, generating the GN mutants GNL46A, GNE47A, GNE48A, GNG49A, and GNL50A. VLPs obtained from cells transfected without or with wt GN/GC served as negative (lane 1) and positive (lane 2) controls, respectively. (B) Intracellular localization of the GN single-amino-acid glycoprotein mutants that were assayed for CAT activity in panel A. Cells were costained for glycoprotein mutant GN and wt GC (GN/GC; green) and the Golgi marker GM130 (red). The inserts show higher magnifications of the Golgi areas. The panels to the right show the merged images, in which yellow indicates colocalization. (C) Colocalization of the wt GN and GNL46A and GNE47A mutants with the wt GC protein. Cells were transfected with wt GN, GNL46A, and GNE47A in the presence of wt GC and were costained with a polyclonal antibody specifically recognizing the cytoplasmic tail of the GN glycoprotein (green) and a monoclonal antibody specifically recognizing the GC protein (red). The panels to the right show the merged images.
|
The heterodimer of wt GN and GC is transported from the ER to the Golgi complex 45 min after the synthesis of the GC protein (31). To analyze trafficking and transport from the ER to the Golgi complex, wt GN/GC-transfected and mutant GN/wt GC-transfected BHK-21 cells were treated with cycloheximide to block new protein synthesis 5 h posttransfection. The intracellular localization of the transfected proteins was examined by immunofluorescent microscopy 0, 0.5, 1, 2, and 4 h after cycloheximide treatment (Fig. 6 and data not shown). The wt GN/GC heterodimer colocalized well with the Golgi marker at all time points examined, reflecting the efficient transport of the GN/GC heterodimer to the Golgi complex (Fig. 6). The mutants GNL46A, GNE47A, and GNL50A showed partial ER and Golgi complex staining at the beginning of the cycloheximide chase, and the localization of the mutant glycoproteins did not change significantly during the 4-h chase (Fig. 6 and data not shown). These results demonstrate that these three glycoprotein mutants are less efficient in transport to the Golgi complex than the wt glycoprotein.
![]() View larger version (13K): [in a new window] |
FIG. 6. Glycoprotein mutants GNL46A, GNE47A, and GNL50A are partially retained in the ER. BHK-21 cells were transfected with wt and mutant GN, and 5 h posttransfection they were treated with cycloheximide. Cells were fixed, and glycoproteins were detected by immunofluorescence at the beginning of the cycloheximide treatment (time zero) and 4 h posttreatment.
|
![]() View larger version (16K): [in a new window] |
FIG. 7. Analysis of the GC cytoplasmic tail. (A) Alignment of the last seven C-terminal amino acids of the GC proteins from members in the Phlebovirus, Hantavirus, and Orthobunyavirus genera. The conserved lysine is indicated by a gray box. (B) Schematic representation of the GC cytoplasmic tail sequence of the wt GC and the six GC cytoplasmic tail mutants. Residues that were mutated or inverted are underlined. TM, transmembrane domain. (C) CAT activity in cells infected with the VLPs collected from cells transfected with GC cytoplasmic tail mutants and wt GN. (D) Western blot analysis of the supernatants used for VLP infection shown in panel B. VLPs were concentrated and analyzed for the presence of both glycoproteins (GN and wt or mutant GC) and for nucleoprotein (N) (upper panels). The lysates from the corresponding transfected cells also were analyzed for nucleoprotein expression (lower panel).
|
![]() View larger version (22K): [in a new window] |
FIG. 8. Intracellular localization of the GC cytoplasmic tail mutants. (A) BHK-21 cells were transfected with mutant GC and wt GN glycoproteins and analyzed 24 h posttransfection by immunofluorescence microscopy. Cells were costained with polyclonal antibodies recognizing mutant GC and wt GN (green) and with monoclonal antibodies recognizing the Golgi marker GM130 (red). The insert shows a higher magnification of the Golgi area. (B) Colocalization of the wt GN with mutant GCS5A protein. Cells were transfected with GCS5A and costained with a polyclonal antibody specifically recognizing the cytoplasmic tail of the GN glycoproteins (green) and a monoclonal antibody specifically recognizing the GC protein (red). Panels to the right show the merged images.
|
![]() View larger version (30K): [in a new window] |
FIG. 9. Both GN and GC glycoproteins are located at the cell surface in cells transfected with GC cytoplasmic tail mutant GCK3A. BHK-21 cells were transfected with wt GN/GC and mutant GCK3A or GCK4A together with wt GN and were fixed 24 h posttransfection. The cell surface staining of the two glycoproteins GN and GC was detected in nonpermeabilized cells stained with monoclonal antibodies specifically recognizing only the GN or the GC protein.
|
|
|
|---|
Until now, little was known about the budding mechanism of bunyaviruses. Here we have identified two amino acids (L23 and L24) in the cytoplasmic tail of GN that, when changed to alanines, disrupt the release of VLPs. The fact that both glycoproteins, mutant GN as well as wt GC, were correctly targeted and located to the Golgi complex suggested to us that these GN mutants possibly interfered with either the budding or release of particles. Indeed, morphological analysis by high-resolution TEM revealed that the Golgi complex of cells expressing GNL23A were devoid of particles, while the Golgi complex of cells expressing wt GN/GC contained VLPs (Fig. 4B) (30). This was corroborated by the fact that we have been unable to extract any infectious UUK virus VLPs from GNL23A-transfected cells using freeze-thaw (data not shown), indicating the absence of infectious VLPs inside the cell. Previously, a temperature-sensitive mutant of UUK virus (ts12) was reported to be unable to generate and release virus particles at the restrictive temperature (39°C) (11, 12). Both glycoproteins accumulated in the Golgi membrane but were unable to initiate budding, resulting in large vacuolization of the Golgi complex. The function of the Golgi complex remained intact, and at a lower temperature (32°C) virus particles could be produced (13, 14). However, we did not observe an increase in VLP formation at lower temperatures, indicating that our GN mutants are not temperature sensitive. This indicates that although the GNL23A mutant morphologically resembles the ts12 mutant, the mechanism by which particle formation in the Golgi complex is blocked appears to be different.
The cytoplasmic tail of UUK virus GN was shown to be palmitoylated at its two cysteines (C25 and C28), but the functional significance of this modification has remained unknown (2). Palmitoylation was reported to be important for the budding process of other viruses, such as Sindbis virus (19), retroviruses (36), rubella virus (43), coronavirus (41), and influenza virus (5). We were unable to detect any changes in intracellular distribution, particle formation, and release when both cysteines in the GN cytoplasmic tail of UUK virus were changed to alanines (reference 29 and the present study), demonstrating that palmitoylation of GN is not important for the formation of infectious VLPs.
Moreover, we found that the proper intracellular targeting of the two glycoproteins is critical for the budding and release of particles. Particles were not generated when the GN/GC proteins were localized to the ER. It is known that the UUK virus already starts to bud in the ER-Golgi intermediate compartment, but no UUK virus budding was observed to occur in the ER (20). Three GN glycoprotein mutants showing similar intracellular distributions located to both the ER and Golgi complex did not have the same ability to generate VLPs as the wt Golgi complex-located glycoproteins. Although we demonstrated that all three GN mutants were less efficient in ER exit, only two mutants, GNL46A and GNL50A, could not generate and release VLPs at all, while the GNE47A mutant could transfer some CAT activity. At the moment, we cannot rule out that the introduction of some of these mutations might have an additional effect on the formation or release of VLPs, resulting in the complete absence of VLPs. It was hypothesized that mutation of these residues in the GN cytoplasmic tail disrupted heterodimer formation with the wt GC, resulting in ER retention of GC, while GN was still able to exit the ER and was transported to the Golgi complex, as is known to occur when these proteins are expressed alone (26). Simultaneous detection of the mutated GN and wt GC clearly showed that both glycoproteins are always colocalized, in the ER as well as in the Golgi membrane, implying that they still are able to form heterodimers. These results indicate that mutation of residues L46, E47, and L50 in the GN cytoplasmic tail interferes with the correct targeting of the GN/GC heterodimers to the Golgi complex, the site where budding occurs, resulting in no or strongly reduced release of infectious particles. The GC was proposed to contain an ER retention signal in its short cytoplasmic tail (15, 37), and masking of this signal through heterodimerization with the GN might be a requirement for its exit out of the ER and entry into the secretory pathway. Our results suggest that the masking of this GC ER retention signal may be disrupted when residues L46, E47, and L50 are mutated, leading to the ER retention of the GN/GC heterodimers. No conservation of amino acids 46 to 50 was observed between the cytoplasmic tail of UUK virus GN and other phleboviruses (reference 17 and data not shown).
The five-amino-acid GC cytoplasmic tail postulated to contain an ER retention signal (15, 37) was also analyzed by a mutagenesis screen. We found that two residues, the third residue, a lysine, and the last residue, a serine, were important for the proper localization of both glycoproteins. Mutation of the residue K3 in GCK3A resulted in the expression of both GC and GN at the cell surface, in addition to its Golgi complex localization. Mutation of residue S5 effectively prevented both glycoproteins from exiting the ER, suggesting that mutation of this residue interferes with the ER-to-Golgi complex trafficking. Although we observed a similar phenotype for the GCK3A and GC invert mutants, a lysine is present at position 3 in the GC invert mutant, indicating that the effect of this amino acid also is context dependent. This indicates that residue K3 plays a role in the retention of the glycoprotein heterodimer in the Golgi membrane, thereby allowing the efficient formation of infectious particles. In addition to its proposed role in ER retention, K3 also is involved in the retention of the glycoprotein heterodimers in the Golgi membrane. We hypothesize that mutation of this conserved lysine residue affects the interaction with the GN cytoplasmic tail and possibly alters the secondary structure of the Golgi retention motif, previously found to be localized between residues 10 and 40. This would lead to inefficient Golgi retention of the heteromeric glycoprotein complex, leading to transport to the plasma membrane. Interestingly, this residue is absolutely conserved among the Phlebovirus, Hantavirus, and Orthobunyavirus genera. Most GC proteins of the different members in the Bunyaviridae family are retained in the ER when expressed alone, although Punta Toro virus GC has been shown to reach the plasma membrane despite the presence of the conserved lysine at position –3 (6).
In the present study we demonstrate, using a VLP system for UUK virus, that the cytoplasmic tails of both GN and GC contain specific motifs essential for the virus life cycle. In a previous study, four amino acids in the GN cytoplasmic tail were shown to be involved in the packaging through a direct interaction between the RNPs and the viral spike proteins (29). Here we continued our analysis of the glycoprotein cytoplasmic tails and showed that leucine at position 23 and, to a lesser extent, at position 24 in the GN tail are important for the initiation of VLP budding in the Golgi membrane. For many viruses it has been established that the matrix protein is the major determinant for budding (16, 18, 21, 28, 40), and specific motifs in the matrix proteins, so-called late domains, have been identified that are known to interact with cellular factors to enable the budding of enveloped viruses (4, 10). We have not been able to identify a late domain in the GN or GC cytoplasmic tail that could be involved in VLP formation. Also, bunyaviruses do not contain a matrix protein, and we have shown that the two glycoproteins alone can generate particles (29, 30). So far, the exact mechanism for how bunyaviruses bud into the Golgi membrane and if additional cellular factors are required for this process are not known. We also show that the cellular localization of the two glycoproteins GN and GC is important for generation of VLPs and that specific residues, other than the previously identified Golgi complex retention motif (residues 10 to 40), play an important role in intracellular targeting of the viral spike proteins. These results, together with our identification of the packaging signal, give a better understanding of the biogenesis of UUK virus and other, more clinically relevant members of the Bunyaviridae family.
Published ahead of print on 1 August 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»